世界の神経内科デバイスの市場規模は、2023年に118億7000万ドルと評価され、2024年から2030年にかけて8.8%のCAGRで成長すると予測されます。神経疾患の増加、神経内科デバイスへの民間企業からの多額の投資、および神経療法の研究開発の強化の結果として、市場は拡大しています。アルツハイマー病、脳卒中、パーキンソン病、てんかんなどの神経疾患の有病率の増加により、高度な診断および治療機器の必要性が高まっています。さらに、高齢者人口の増加は、市場を牽引する重要な要因です。例えば、国連人口基金の予測によると、65歳以上の割合は5.5%から10.3%へとほぼ倍増し、今後はさらに倍増し、2024年から2074年の間に20.7%に達すると予想されています。高齢者は神経障害を発症するリスクが高く、これらの問題に対処するためのデバイスの必要性が高まっています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Neurology Devices Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Neurology Devices Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Neurology Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Neurology Devices Market: Product Movement Analysis, 2024 & 2030 (USD Billion)
4.3. Neurostimulation
4.3.1. Neurostimulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Interventional Neurology
4.4.1. Interventional Neurology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.5. CSF Management
4.5.1. CSF Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6. Neurosurgery
4.6.1. Neurosurgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Neurology Devices Market: Regional Estimates & Trend Analysis
5.1. Neurology Devices Market Share, By Region, 2024 & 2030 (USD Billion)
5.2. North America
5.2.1. North America Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. U.S. Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Canada Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.4. Mexico
5.2.4.1. Mexico Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3. Europe
5.3.1. Europe Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. U.K.
5.3.2.1. U.K. Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Germany
5.3.3.1. Germany Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. Italy
5.3.4.1. Italy Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. Spain
5.3.5.1. Spain Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.6. Denmark
5.3.6.1. Denmark Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.7. Sweden
5.3.7.1. Sweden Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.8. Norway
5.3.8.1. Norway Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. China
5.4.2.1. China Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Japan
5.4.3.1. Japan Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. India
5.4.4.1. India Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.5. South Korea
5.4.5.1. South Korea Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.6. Australia
5.4.6.1. Australia Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.7. Thailand
5.4.7.1. Thailand Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Brazil Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3. Argentina
5.5.3.1. Argentina Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Middle East and Africa
5.6.1. Middle East and Africa Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.2. Saudi Arabia
5.6.2.1. Saudi Arabia Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.3. UAE
5.6.3.1. UAE Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.4. South Africa
5.6.4.1. South Africa Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.5. Kuwait
5.6.5.1. Kuwait Neurology Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Heat Map Analysis
6.4. Company Profiles
6.4.1. Medtronic
6.4.1.1. Participant’s Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Recent Developments/ Strategic Initiatives
6.4.2. Johnson and Johnson Services Inc.
6.4.2.1. Participant’s Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Recent Developments/ Strategic Initiatives
6.4.3. Penumbra, Inc.
6.4.3.1. Participant’s Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Recent Developments/ Strategic Initiatives
6.4.4. MicroPort Scientific Corporation
6.4.4.1. Participant’s Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Recent Developments/ Strategic Initiatives
6.4.5. Stryker
6.4.5.1. Participant’s Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Recent Developments/ Strategic Initiatives
6.4.6. TERUMO CORPORATION
6.4.6.1. Participant’s Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Recent Developments/ Strategic Initiatives
